NCT03444766View on ClinicalTrials.gov

Study of Nivolumab for Advanced Cancers in India

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

July 17, 2019

Study Completion Date

July 17, 2019

Conditions
Non-Small Cell Lung Cancer (NSCLC)Non-Small-Cell Lung CarcinomaNonsmall Cell Lung CancerKidney CancerKidney NeoplasmsRenal CancerRenal Neoplasms
Interventions
DRUG

Nivolumab

specified dose on specified days

Trial Locations (9)

110029

Local Institution, New Delhi

302004

Local Institution, Jaipur

400012

Local Institution, Mumbai

500034

Local Institution, Hyderabad

560027

Local Institution, Bangalore

560054

Local Institution, Bengaluru

560072

Local Institution, Bangalore

632004

Local Institution, Vellore

700156

Local Institution, Kolkata

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03444766 - Study of Nivolumab for Advanced Cancers in India | Biotech Hunter | Biotech Hunter